Glycate
NDC Package 59547-210-19
Package Information
Glycate is glycopyrrolate is used with other drugs to treat a certain type of stomach/intestinal ulcer (peptic ulcer). Marketed by Nuro Pharma, Inc., this product is identified by NDC 59547-210 and is authorized under FDA application ANDA091522.
Identification & Billing
- RxCUI: 1247658 - glycopyrrolate 1.5 MG Oral Tablet
- RxCUI: 1437975 - Glycate 1.5 MG Oral Tablet
- RxCUI: 1437975 - glycopyrrolate 1.5 MG Oral Tablet [Glycate]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 59547 - Nuro Pharma, Inc.
- 59547-210 - Glycate
- 59547-210-19 - 100 TABLET in 1 BOTTLE, PLASTIC
- 59547-210 - Glycate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 59547-210-19 identifies a specific commercial package of 100 tablet in 1 bottle, plastic of Glycate, labeled by Nuro Pharma, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Nuro Pharma, Inc. on March 12, 2012. The current certification is valid through December 31, 2018.
What are the primary indications for this medication?
Glycopyrrolate is used with other drugs to treat a certain type of stomach/intestinal ulcer (peptic ulcer). This medication may help relieve stomach/abdominal pain. However, it has not been shown to be effective in healing these ulcers, preventing them from returning, or preventing other problems caused by ulcers. Glycopyrrolate works by decreasing the amount of acid in the stomach. It also slows the natural movements of the gut and relaxes the muscles in the stomach/intestines. Glycopyrrolate belongs to a class of drugs known as anticholinergics.
How is this Nuro Pharma, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 59547021019. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.